今日盘中，港股生物医药板块整体走强，其中药捷安康-B（02617）表现突出，股价大涨7.16%，引发市场关注。
除药捷安康-B外，多只生物医药股同步走高。科笛-B（02487）涨幅最为显著，超过12%；和铂医药-B（02142）紧随其后，涨幅超过9%。此外，荣昌生物（09995）、科济药业-B（02171）涨幅均超过6%，药明生物（02269）也上涨超过5%。
生物医药板块的集体上涨反映了投资者对该行业的积极预期。作为该板块的重要成员，药捷安康-B的强劲表现不仅体现了公司自身的发展潜力，也反映了整个行业的向好趋势。投资者可持续关注该板块的后续发展动向。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.